LumiraDx Inc: Point of Care (POC) Survey Reveals Majority of U.K. Clinicians Endorse Climate Benefits of POC Through Reduction of Carbon Emissions and Anticipate Future Growth of POC Testing to Come from Community Settings

LumiraDx shares these and other findings from its first annual U.K. survey "Point of Care Diagnostics: A Clinicians View"LONDON, Dec. 08, 2022 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: LMDX), a next-generation

Related Keywords

United Kingdom ,London ,City Of ,Pooja Pathak ,Care Networks Pcns ,Lumiradx Limited Nasdaq ,Vcare Diagnostics ,Primary Care Networks ,Integrated Care ,Lumiradx Chief Product ,Lumiradx ,Joint ,Mare ,Survey ,Eveals ,Majority ,Clinicians ,Endorse ,Climate ,Benefits ,Through ,Reduction ,Carbon ,Emissions ,Nticipate ,Future ,Growth ,Testing ,Rome ,Rom ,Community ,Settings ,